ClinicalTrials.gov record
Completed Phase 2 Interventional

Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma

ClinicalTrials.gov ID: NCT00006385

Public ClinicalTrials.gov record NCT00006385. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 9:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Evaluation of Immunization With an HLA-A2 Multi-Epitope Peptide Vaccine Containing MART-1 (NSC #672643), gp100 (NSC #683472), and Tyrosinase (NSC #699048) Peptides Alone or in Combination With GM-CSF, IFN Alpha-2b, or GM-CSF + IFN Alpha-2b in Patients With Metastatic Melanoma

Study identification

NCT ID
NCT00006385
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eastern Cooperative Oncology Group
Network
Enrollment
Not listed

Conditions and interventions

Interventions

  • MART-1 antigen Biological
  • gp100 antigen Biological
  • incomplete Freund's adjuvant Biological
  • recombinant interferon alfa Biological
  • sargramostim Biological
  • tyrosinase peptide Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2000
Primary completion
Sep 30, 2006
Completion
Not listed
Last update posted
Nov 7, 2011

Started 2000

United States locations

U.S. sites
32
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
CCOP - Scottsdale Oncology Program Scottsdale Arizona 85259-5404
Emory University Hospital - Atlanta Atlanta Georgia 30322
Veterans Affairs Medical Center - Atlanta (Decatur) Decatur Georgia 30033
Veterans Affairs Medical Center - Lakeside Chicago Chicago Illinois 60611-4494
Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago Illinois 60611
CCOP - Evanston Evanston Illinois 60201
CCOP - Carle Cancer Center Urbana Illinois 61801
Indiana University Cancer Center Indianapolis Indiana 46202-5289
Veterans Affairs Medical Center - Indianapolis (Roudebush) Indianapolis Indiana 46202
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1016
CCOP - Wichita Wichita Kansas 67214-3882
CCOP - Ochsner New Orleans Louisiana 70121
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231
Tuft-New England Medical Center Boston Massachusetts 02111
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731
CCOP - Northern New Jersey Hackensack New Jersey 07601
Cancer Institute of New Jersey New Brunswick New Jersey 08903
Albert Einstein Clinical Cancer Center The Bronx New York 10461
Ireland Cancer Center Cleveland Ohio 44106-5065
CCOP - Toledo Community Hospital Toledo Ohio 43623-3456
CCOP - Geisinger Clinic and Medical Center Danville Pennsylvania 17822-2001
University of Pennsylvania Cancer Center Philadelphia Pennsylvania 19104
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15213-3489
CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota 57104
CCOP - Scott and White Hospital Temple Texas 76508
Cancer Center at the University of Virginia Charlottesville Virginia 22908
CCOP - St. Vincent Hospital Cancer Center, Green Bay Green Bay Wisconsin 54301
Veterans Affairs Medical Center - Madison Madison Wisconsin 53705-2286
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792-0001
CCOP - Marshfield Medical Research and Education Foundation Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00006385, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 7, 2011 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00006385 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →